Position in PFE
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$104,964
-$17,436 QoQ
Shares Held
4,359
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,536
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026West Branch Capital LLC holds $28,624,658 across 10 Drug Manufacturers - General names. PFE ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,703 | $10,438,640 | |
| 2 | JNJ |
Johnson & Johnson
|
33,416 | $8,486,661 | |
| 3 | ABBV |
AbbVie Inc.
|
30,433 | $7,658,160 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,301 | $1,066,678 | |
| 5 | AMGN |
Amgen Inc
|
1,167 | $422,594 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,186 | $276,179 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,350 | $135,407 | |
| 8 | PFE |
Pfizer Inc
This page
|
4,359 | $104,964 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,964 | 4,359 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $122,400 | 4,359 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $108,539 | 4,359 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $111,067 | 4,359 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $88,815 | 3,664 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $92,845 | 3,664 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $92,483 | 3,486 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $101,058 | 3,492 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $97,566 | 3,487 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $76,812 | 2,768 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $80,468 | 2,795 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $1,871,550 | 56,423 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $2,021,508 | 55,112 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,228,128 | 54,611 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,765,320 | 53,968 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $2,325,318 | 53,138 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $2,767,307 | 52,781 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $2,697,372 | 52,103 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $3,134,492 | 53,082 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $2,220,692 | 51,632 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,019,559 | 51,572 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $1,806,137 | 49,852 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,967,715 | 53,456 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,924,215 | 52,431 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,692,030 | 51,744 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $1,477,937 | 45,280 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||